News

Dandy Launches America’s First Two-Visit Dentures for Medicaid, Medicare, and Low-Paying PPOs

Top-quality dentures. Affordable by design. Delivered in two appointmentsNEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Dandy, America’s fully digital…

6 months ago

Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors

Figure: 1 Palisade Bio, Inc. Appoints Emil Chuang, MB BS FRACP to its Board of Directors Veteran clinical leader with…

6 months ago

Qanatpharma, Zuse Institute Berlin, Enamine, and Proteros biostructures Announce Generative-AI Driven Lead Discovery Collaboration

Joint research program targets new treatments for life-threatening complication of brain hemorrhage An international discovery collaboration is harnessing AI-powered drug…

6 months ago

Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans

Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial  Recent…

6 months ago

Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines

Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery System; Company is Currently Conducting…

6 months ago

Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045

Application Update Based on Extensive Review of DataGLEN ALLEN, Va., July 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:…

6 months ago

Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements

NEWTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech…

6 months ago

Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law

Fountain Life operates four flagship longevity centers, including two in Florida, where a new state law effective July 1, 2025,…

6 months ago

Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

Tegoprubart to be Used as Immunosuppressive Agent in Cohort C of Sernova’s Phase 1/2 Cell Pouch Bio-hybrid Organ Clinical Trial…

6 months ago

Ernexa Therapeutics Regains Compliance with Nasdaq Listing Requirements

CAMBRIDGE, Mass., July 09, 2025 (GLOBE NEWSWIRE) --  Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of…

6 months ago